Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial

Sarah Glewis; Marliese Alexander; Senthil Lingaratnam; Benjamin Lee; Ian Campbell; Mei Krishnasamy; Maarten IJzerman; Mussab Fagery; Sam Harris; Chloe Georgiou; Craig Underhill; Mark Warren; Robert Campbell; Jennifer Martin; Jeanne Tie; Michael Michael

doi:10.1080/0284186x.2022.2109423

Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial

Sarah Glewis^*, Marliese Alexander, Senthil Lingaratnam, Benjamin Lee, Ian Campbell, Mei Krishnasamy, Maarten IJzerman, Mussab Fagery, Sam Harris, Chloe Georgiou, Craig Underhill, Mark Warren, Robert Campbell, Jennifer Martin, Jeanne Tie, Michael Michael

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

6 Citations (Scopus)

Original language	English
Pages (from-to)	1136-1139
Number of pages	4
Journal	Acta Oncologica
Volume	61
Issue number	9
Early online date	16 Aug 2022
DOIs	https://doi.org/10.1080/0284186x.2022.2109423
Publication status	Published - 2022
Externally published	Yes

Bibliographical note

Funding Information:
This work was supported by the International Society of Oncology Pharmacy Practitioners (ISOPP) under ISOPP Research Grant Award.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/0284186x.2022.2109423

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2022.2109423?needAccess=true

Cite this

Glewis, S., Alexander, M., Lingaratnam, S., Lee, B., Campbell, I., Krishnasamy, M., IJzerman, M., Fagery, M., Harris, S., Georgiou, C., Underhill, C., Warren, M., Campbell, R., Martin, J., Tie, J., & Michael, M. (2022). Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial. Acta Oncologica, 61(9), 1136-1139. https://doi.org/10.1080/0284186x.2022.2109423

@article{a879fa5b64fa408497e416e79ebe3bc4,

title = "Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial",

author = "Sarah Glewis and Marliese Alexander and Senthil Lingaratnam and Benjamin Lee and Ian Campbell and Mei Krishnasamy and Maarten IJzerman and Mussab Fagery and Sam Harris and Chloe Georgiou and Craig Underhill and Mark Warren and Robert Campbell and Jennifer Martin and Jeanne Tie and Michael Michael",

note = "Funding Information: This work was supported by the International Society of Oncology Pharmacy Practitioners (ISOPP) under ISOPP Research Grant Award.",

year = "2022",

doi = "10.1080/0284186x.2022.2109423",

language = "English",

volume = "61",

pages = "1136--1139",

journal = "Acta Oncologica",

issn = "0284-186X",

publisher = "Medical Journals Sweden AB",

number = "9",

}

Glewis, S, Alexander, M, Lingaratnam, S, Lee, B, Campbell, I, Krishnasamy, M, IJzerman, M, Fagery, M, Harris, S, Georgiou, C, Underhill, C, Warren, M, Campbell, R, Martin, J, Tie, J & Michael, M 2022, 'Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial', Acta Oncologica, vol. 61, no. 9, pp. 1136-1139. https://doi.org/10.1080/0284186x.2022.2109423

Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial. / Glewis, Sarah; Alexander, Marliese; Lingaratnam, Senthil et al.
In: Acta Oncologica, Vol. 61, No. 9, 2022, p. 1136-1139.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx)

T2 - study protocol of a multicentre clinical trial

AU - Glewis, Sarah

AU - Alexander, Marliese

AU - Lingaratnam, Senthil

AU - Lee, Benjamin

AU - Campbell, Ian

AU - Krishnasamy, Mei

AU - IJzerman, Maarten

AU - Fagery, Mussab

AU - Harris, Sam

AU - Georgiou, Chloe

AU - Underhill, Craig

AU - Warren, Mark

AU - Campbell, Robert

AU - Martin, Jennifer

AU - Tie, Jeanne

AU - Michael, Michael

N1 - Funding Information: This work was supported by the International Society of Oncology Pharmacy Practitioners (ISOPP) under ISOPP Research Grant Award.

PY - 2022

Y1 - 2022

UR - http://www.scopus.com/inward/record.url?scp=85136193151&partnerID=8YFLogxK

U2 - 10.1080/0284186x.2022.2109423

DO - 10.1080/0284186x.2022.2109423

M3 - Article

C2 - 35972781

SN - 0284-186X

VL - 61

SP - 1136

EP - 1139

JO - Acta Oncologica

JF - Acta Oncologica

IS - 9

ER -

Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial

Bibliographical note

UN SDGs

Access to Document

Other files and links

Cite this